“Myriapod Complete Tumor Signature” Project

Diatech Pharmacogenetics is pleased to announce its participation in the cascade funding calls within the THE – TUSCANY HEALTH ECOSYSTEM, PRECISION MEDICINE & PERSONALIZED HEALTHCARE, with a project focused on developing a multigene signature (over 100 genes) for the detection of DNA and RNA in the oncology field. Cascade funding call issued by Spoke 6 […]

Pharmacogenetic Passport Project – Development of a Genetic Passport for Pharmacogenetics based on Next Generation Sequencing

Diatech Pharmacogenetics is pleased to announce its participation in the cascade funding calls within the ECOSYSTEM VITALITY – INNOVATIVE THERAPEUTIC APPROACHES: NEW CHEMICAL ENTITIES, BIOLOGICS AND DRUG DELIVERY, SPOKE 8, with a project aimed at developing a genetic passport for pharmacogenetics based on Next Generation Sequencing. CASCADE CALL – ECOSYSTEM VITALITY – INNOVATIVE THERAPEUTIC APPROACHES: […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving this research use-only area

You are about to access content intended for a different region. Information, regulatory status, and product availability may vary by location.

Do you wish to continue?

Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.